Crossref
Hypereosinophilia under dupilumab therapy in CRSwNP – Different faces of a hematologic side effect?
Laryngo-Rhino-Otologie · 01.05.2024 · 103 (S 02 S 02) · S325
DOI: 10.1055/s-0044-1785102 ↗Kurz gefasst
Fachartikel in der Zeitschrift Laryngo-Rhino-Otologie, erschienen am 01.05.2024. Verfasst von Marianne Zabel und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Hypereosinophilia under dupilumab therapy in CRSwNP – Different faces of a hematologic side effect?
Zitieren
APA
Zabel, M., Radeloff, A., & Böscke, R. (2024). Hypereosinophilia under dupilumab therapy in CRSwNP – Different faces of a hematologic side effect?. Laryngo-Rhino-Otologie, 103(S 02 S 02), S325. https://doi.org/10.1055/s-0044-1785102
Vancouver
Zabel M, Radeloff A, Böscke R. Hypereosinophilia under dupilumab therapy in CRSwNP – Different faces of a hematologic side effect?. Laryngo-Rhino-Otologie. 2024;103(S 02 S 02):S325. doi:10.1055/s-0044-1785102
BibTeX
@article{Zabel2024,
author = {Zabel, Marianne and Radeloff, Andreas and Böscke, Robert},
title = {Hypereosinophilia under dupilumab therapy in CRSwNP – Different faces of a hematologic side effect?},
journal = {Laryngo-Rhino-Otologie},
year = {2024},
volume = {103},
number = {S 02 S 02},
pages = {S325},
doi = {10.1055/s-0044-1785102}
}
EUVIMED